1. Home
  2. ALLO vs CHMG Comparison

ALLO vs CHMG Comparison

Compare ALLO & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

452.6M

Sector

Health Care

ML Signal

HOLD

Logo Chemung Financial Corp

CHMG

Chemung Financial Corp

SELL

Current Price

$83.20

Market Cap

415.9M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
ALLO
CHMG
Founded
2017
1833
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
452.6M
415.9M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
ALLO
CHMG
Price
$0.76
$83.20
Analyst Decision
Strong Buy
Buy
Analyst Count
12
5
Target Price
$9.00
★ $92.35
AVG Volume (30 Days)
★ 11.2M
48.8K
Earning Date
11-05-2026
10-22-2026
Dividend Yield
N/A
★ 1.73%
EPS Growth
★ 34.09
N/A
EPS
N/A
★ 6.36
Revenue
N/A
N/A
Revenue This Year
N/A
$31.95
Revenue Next Year
$72.02
$7.35
P/E Ratio
★ N/A
$13.10
Revenue Growth
N/A
★ N/A
52 Week Low
$0.74
$50.31
52 Week High
$4.46
$89.34

Technical Indicators

Market Signals
Indicator
ALLO
CHMG
Relative Strength Index (RSI) 21.26 45.29
Support Level N/A $79.30
Resistance Level $2.25 $84.69
Average True Range (ATR) 0.10 2.02
MACD -0.02 -0.32
Stochastic Oscillator 0.42 4.31

Price Performance

Historical Comparison
ALLO
CHMG

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

Share on Social Networks: